Lipopolysaccharides from Escherichia coli O111:B4, Ready Made solution, 1 mg/mL, 0.2 μm filtered

Cat. No.: XGB677

Lipopolysaccharides from Escherichia coli O111:B4, Ready Made solution, 1 mg/mL, 0.2 μm filtered

Synonym: LPS

  • MDL: MFCD00164401
  • NACRES: NA.25
Product Size
2 mL
Price
Datasheet
MSDS
Properties
Biological Source
Escherichia coli (O111:B4)
Form
aqueous solution
Purity
Ready Made solution, 1 mg/mL, 0.2 μm filtered
Quality Level
200
Applications
Lipopolysaccharides from Escherichia coli O111:B4 has been used:• to stimulate an inflammatory response in porcine liver tissues in vivo and piglet ileum tissues ex vivo • Stimulate natural killer (NK) cells and hepatic B cells ex vivo • Induce arthritis in a standard rabbit model Lipopolysaccharides (LPSs) are characteristic components of the cell wall of Gram-negative bacteria. LPS and its lipid A moiety stimulate cells of the innate immune system by the Toll-like receptor 4 (TLR4), a member of the Toll-like receptor protein family, which recognizes common pathogen-associated molecular-patterns (PAMPs).
Storage
2-8°C
Safety Information
Personal Protective Equipment
Eyeshields, Gloves, half-mask respirator (US), multi-purpose combination respirator cartridge (US)
WGK Germany
WGK 3
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0